EUVIMEDEUVIMED entdecken
Crossref

Serum Creatine Phosphokinase as a Biomarker in Organophosphate Poisoning

Mürsel Koçer

Eurasian Journal of Toxicology · 15.05.2026 · 8 (1) · 15-16

DOI: 10.51262/ejtox.1873843 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eurasian Journal of Toxicology, online erschienen am 15.05.2026. Verfasst von Mürsel Koçer.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Organophosphorus (OP) poisoning is a significant public health problem, particularly in developing countries, and there is a need for accessible biomarkers. This paper evaluates the study entitled “Serum Creatine Phosphokinase as a Biomarker in Organophosphorus Poisoning.” The study's strengths include the correlation between serum creatine phosphokinase (CPK) levels and poisoning severity, and its cost-effectiveness as a test. However, the limited sample size and the small number of patients in the severe poisoning group limit the generalizability of the results. Furthermore, the specificity issues of CPK and concomitant clinical conditions that may affect its levels should be considered. In conclusion, while CPK is a promising biomarker in OP poisoning, more comprehensive studies are needed to clarify its clinical use.

Zitieren

APA

Koçer, M. (2026). Serum Creatine Phosphokinase as a Biomarker in Organophosphate Poisoning. Eurasian Journal of Toxicology, 8(1), 15-16. https://doi.org/10.51262/ejtox.1873843

Vancouver

Koçer M. Serum Creatine Phosphokinase as a Biomarker in Organophosphate Poisoning. Eurasian Journal of Toxicology. 2026;8(1):15-16. doi:10.51262/ejtox.1873843

BibTeX
@article{Koer2026,
  author = {Koçer, Mürsel},
  title = {Serum Creatine Phosphokinase as a Biomarker in Organophosphate Poisoning},
  journal = {Eurasian Journal of Toxicology},
  year = {2026},
  volume = {8},
  number = {1},
  pages = {15--16},
  doi = {10.51262/ejtox.1873843}
}
Kostenlos starten →